Podcast on B Cell-Targeting Therapies and Other Multiple Sclerosis Concerns During COVID-19 Robert K. ShinPavle RepovicJoseph R. Berger Commentary Open access 23 January 2022 Pages: 515 - 524
The Humanistic and Economic Burden of Alzheimer's Disease Amir Abbas Tahami MonfaredMichael J. ByrnesQuanwu Zhang Review Open access 22 February 2022 Pages: 525 - 551
Alzheimer’s Disease: Epidemiology and Clinical Progression Amir Abbas Tahami MonfaredMichael J. ByrnesQuanwu Zhang Review Open access 14 March 2022 Pages: 553 - 569
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review Gavin GiovannoniJoela Mathews Review Open access 23 March 2022 Pages: 571 - 595
Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review Juliette C. ThompsonFrançois-Xavier ChaletDarren A. Talbot Review Open access 20 April 2022 Pages: 597 - 620
Bioavailability and Safety of a New Highly Concentrated Midazolam Nasal Spray Compared to Buccal and Intravenous Midazolam Treatment in Chinese Healthy Volunteers Hui WangJie HuangGuo-ping Yang Original Research Open access 07 February 2022 Pages: 621 - 632
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study Caroline PapeixGiovanni CastelnovoThe Virgile Study Group Original Research Open access 11 February 2022 Pages: 633 - 658
Mapping Motor Pathways in Parkinson’s Disease Patients with Subthalamic Deep Brain Stimulator: A Diffusion MRI Tractography Study Yan LiNaying HeDianyou Li Original Research Open access 14 February 2022 Pages: 659 - 677
Effects of Training with a Brain–Computer Interface-Controlled Robot on Rehabilitation Outcome in Patients with Subacute Stroke: A Randomized Controlled Trial Chen-Guang ZhaoFen JuHua Yuan Original Research Open access 16 February 2022 Pages: 679 - 695
Predictors of Prolonged Mechanical Ventilation Among Patients with Aneurysmal Subarachnoid Hemorrhage After Microsurgical Clipping Ching-Hua HuangShih-Ying NiLu-Ting Kuo Original Research Open access 20 February 2022 Pages: 697 - 709
Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses Rajesh PahwaJason AldredStuart H. Isaacson Original Research Open access 22 February 2022 Pages: 711 - 723
Results from Patient Interviews on Fatigue in Progressive Multiple Sclerosis and Evaluation of Fatigue Patient-Reported Outcome (PRO) Instruments Crystal WatsonKayla ScippaJason C. Cole Original Research Open access 09 March 2022 Pages: 725 - 739
COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab Anne H. CrossSilvia DelgadoKevin Winthrop Original Research Open access 13 March 2022 Pages: 741 - 758
Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab Anne H. CrossSilvia DelgadoKevin Winthrop Correction Open access 03 May 2022 Pages: 759 - 762
Clinical Characteristics and Prognostic Significance of Subclinical Seizures in Focal Epilepsy: A Retrospective Study Chenmin HeCong ChenShan Wang Original Research Open access 04 April 2022 Pages: 763 - 779
Pharmacokinetics of XEN496, a Novel Pediatric Formulation of Ezogabine, Under Fed and Fasted Conditions: A Phase 1 Trial Rostam NamdariConstanza LuzonGregory N. Beatch Original Research Open access 05 April 2022 Pages: 781 - 796
Efficacy of Plasma Exchange Treatment for Demyelinating Optic Neuritis Associated with Various Serum Antibodies: A Prospective Cohort Study Junxia FuYongping WangShihui Wei Original Research Open access 09 April 2022 Pages: 797 - 813
Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study Chong YanRui-Sheng DuanChongbo Zhao Original Research Open access 12 April 2022 Pages: 815 - 834
Assessing Risk for Relapse among Children with Infantile Spasms Using the Based Score after ACTH Treatment: A Retrospective Study Lin WanYan-Qin LeiGuang Yang Original Research Open access 15 April 2022 Pages: 835 - 849
Comparative Effectiveness of Carbidopa–Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson’s Disease-Related Pill Burden Reduction in Advanced Parkinson’s Disease: A Retrospective Real-World Cohort Study Michael J. SoileauFernando PaganMustafa S. Siddiqui Original Research Open access 20 April 2022 Pages: 851 - 861
Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling Amir Abbas Tahami MonfaredAli TafazzoliQuanwu Zhang Original Research Open access 25 April 2022 Pages: 863 - 880
White Matter and Alzheimer’s Disease: A Bidirectional Mendelian Randomization Study Yaqing LiJiaxin ZhengJunjian Zhang Original Research Open access 03 May 2022 Pages: 881 - 892
Low Recruitment in a Double-Blind, Placebo-Controlled Trial of Ocrelizumab for Autoimmune Encephalitis: A Case Series and Review of Lessons Learned Kyle M. BlackburnDavid A. DenneySteven A. Vernino Brief Report Open access 07 February 2022 Pages: 893 - 903
Intrathecally Expanding B Cell Clones in Herpes Simplex Encephalitis: A Case Report Shila P. Coronel-CastelloGildas LepennetierKlaus Lehmann-Horn Case Report Open access 06 February 2022 Pages: 905 - 913
Correction to: Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis Amir Abbas Tahami MonfaredKatherine Houghtonfor the Alzheimer’s Disease Neuroimaging Initiative Correction Open access 18 March 2022 Pages: 915 - 927
Correction to: Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched Controls Emma ViscidiManeesh JunejaSusan Hall Correction Open access 04 May 2022 Pages: 929 - 930
